Home » Topics » BioWorld Science

BioWorld Science
RSS

Ferring permitted to resume marketing of Repronex

Aug. 18, 1997

NPS Pharmaceuticals: Q2 1997 highlights

Aug. 14, 1997

NABI: Q2 1997 highlights

Aug. 14, 1997

Atrix: Q2 1997 highlights

Aug. 14, 1997

Gilead: Q2 1997 highlights

Aug. 14, 1997

Forest: Fiscal Q1 highlights

Aug. 14, 1997

Patent allowances granted to Genelabs for DNA-binding technology

Aug. 14, 1997

NIH research grant goes to Diatide for arterial thrombosis therapy

Aug. 14, 1997

Alteon receives U.S. patent for AGE cross-link breakers

Aug. 14, 1997

Zomig approved in Germany, Denmark and Finland

Aug. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....